Kesimpta & Fatigue

6.4%

of users reported Fatigue

85.1%

also reported Severe reaction

78.2%

are women

Severe reaction

85.1%

Life-threatening condition

5.7%

Hospitalization

5.7%

Disability

3.4%

Kesimpta: general information

10 - 19 years

0.5%

20 - 29 years

8.5%

30 - 39 years

21.7%

40 - 49 years

28.9%

50 - 59 years

26.9%

60 - 69 years

11.7%

70 - 79 years

1.8%